Task: Please answer the following question about the molecule with SMILES Cc1ccc(C(=O)c2ccc(CC(=O)[O-])n2C)cc1.[Na+].
Request: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Result: Approved
Task: Please answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
Cc1ccc(C(=O)c2ccc(CC(=O)[O-])n2C)cc1.[Na+]
Cc1ccc(C(=O)c2ccc(CC(=O)[O-])n2C)cc1.[Na+]
sodium;2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetate
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Approved